Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Dirk Schriefer, Rocco Haase, Nils-Henning Ness & Tjalf Ziemssen. (2022) Cost of illness in multiple sclerosis by disease characteristics – A review of reviews. Expert Review of Pharmacoeconomics & Outcomes Research 22:2, pages 177-195.
Read now
Read now
Oscar Fernández, Miguel Angel Calleja-Hernández, José Meca-Lallana, Celia Oreja-Guevara, Ana Polanco & Ferran Pérez-Alcántara. (2017) Estimate of the cost of multiple sclerosis in Spain by literature review. Expert Review of Pharmacoeconomics & Outcomes Research 17:4, pages 321-333.
Read now
Read now
Articles from other publishers (19)
Elisabet Rodriguez Llorian, Wei Zhang, Amir Khakban, Kristina Michaux, Scott Patten, Anthony Traboulsee, Jiwon Oh, Shannon Kolind, Alexandre Prat, Roger Tam & Larry D Lynd. (2023) Employment status, productivity loss, and associated factors among people with multiple sclerosis. Multiple Sclerosis Journal 29:7, pages 866-874.
Crossref
Crossref
Steven Simoens. (2022) Societal economic burden of multiple sclerosis and cost-effectiveness of disease-modifying therapies. Frontiers in Neurology 13.
Crossref
Crossref
Izumi Kawachi, Hiromichi Otaka, Kosuke Iwasaki, Tomomi Takeshima & Kengo Ueda. (2022) Treatment Status and Healthcare Cost Trends for Patients with Multiple Sclerosis in Japan: A Claims Database Analysis. Neurology and Therapy 11:3, pages 1253-1268.
Crossref
Crossref
Elisabet Rodriguez Llorian, Wei Zhang, Amir Khakban, Scott Patten, Anthony Traboulsee, Jiwon Oh, Shannon Kolind, Alexandre Prat, Roger Tam & Larry D Lynd. (2022) Productivity loss among people with early multiple sclerosis: A Canadian study. Multiple Sclerosis Journal 28:9, pages 1414-1423.
Crossref
Crossref
Tan Guojun, Xu Yan, Wang Weizhi, Wang Lihua, Li Chunyang, Zhang Xinghu, Zhou Hongyu, Dong Huiqing, Zhang Meini, Jin Tao, Yang Huan, Cui Liying & Guo Li. (2022) A multicenter study to evaluate the disease burden and health economics of inpatients with multiple sclerosis in China. Multiple Sclerosis and Related Disorders 60, pages 103732.
Crossref
Crossref
Ana María Maya-Rico, Ángela Londoño-García, Arlex Uriel Palacios-Barahona, Sol Beatriz Jimenez-Tamayo & Estefanía Muriel-Lopera. (2021) Out-of-pocket costs for patients with psoriasis in an outpatient dermatology referral service. Anais Brasileiros de Dermatologia 96:3, pages 295-300.
Crossref
Crossref
Maria Paz-Zulueta, Paula Parás-Bravo, David Cantarero-Prieto, Carla Blázquez-Fernández & Agustín Oterino-Durán. (2020) A literature review of cost-of-illness studies on the economic burden of multiple sclerosis.. Multiple Sclerosis and Related Disorders 43, pages 102162.
Crossref
Crossref
Maria Sá, Carla Cecília Nunes, Ana Martins da Silva, Patrícia Mota & José Pinto-Marques. (2019) JC virus antibodies in Portuguese multiple sclerosis patients: JUSTIFY study results. Journal of the Neurological Sciences 406, pages 116426.
Crossref
Crossref
Celestin Hategeka, Anthony L. Traboulsee, Katrina McMullen & Larry D. Lynd. (2019) Association of Unemployment and Informal Care with Stigma in Multiple Sclerosis. International Journal of MS Care 21:5, pages 214-225.
Crossref
Crossref
Jing Chen, Bruce Taylor, Andrew J Palmer, Andrea Kirk-Brown, Pieter van Dijk, Steve SimpsonJrJr, Leigh Blizzard & Ingrid van der Mei. (2018) Estimating MS-related work productivity loss and factors associated with work productivity loss in a representative Australian sample of people with multiple sclerosis. Multiple Sclerosis Journal 25:7, pages 994-1004.
Crossref
Crossref
M. Krensel, I. Schäfer & M. Augustin. (2019) Modelling first-year cost-of-illness of melanoma attributable to sunbed use in Europe. Journal of the European Academy of Dermatology and Venereology 33, pages 46-56.
Crossref
Crossref
M. Krensel, I. Schäfer & M. Augustin. (2019) Cost-of-illness of melanoma in Europe - a modelling approach. Journal of the European Academy of Dermatology and Venereology 33, pages 34-45.
Crossref
Crossref
Erica Visintin, Michela Tinelli & Panos Kanavos. (2019) Value assessment of disease-modifying therapies for Relapsing-Remitting Multiple Sclerosis: HTA evidence from seven OECD countries. Health Policy 123:2, pages 118-129.
Crossref
Crossref
Jiří Slíva. (2018) Pharmacotherapy of multiple sclerosis in light of the necessary costs associated with prescribing the indicated drug. Neurologie pro praxi 19:4, pages 276-278.
Crossref
Crossref
Xavier Montalban, Ralf Gold, Alan J Thompson, Susana Otero-Romero, Maria Pia Amato, Dhia Chandraratna, Michel Clanet, Giancarlo Comi, Tobias Derfuss, Franz Fazekas, Hans Peter Hartung, Eva Havrdova, Bernhard Hemmer, Ludwig Kappos, Roland Liblau, Catherine Lubetzki, Elena Marcus, David H Miller, Tomas Olsson, Steve Pilling, Krysztof Selmaj, Aksel Siva, Per Soelberg Sorensen, Maria Pia Sormani, Christoph Thalheim, Heinz Wiendl & Frauke Zipp. (2018) ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis. Multiple Sclerosis Journal 24:2, pages 96-120.
Crossref
Crossref
X. Montalban, R. Gold, A. J. Thompson, S. Otero‐Romero, M. P. Amato, D. Chandraratna, M. Clanet, G. Comi, T. Derfuss, F. Fazekas, H. P. Hartung, E. Havrdova, B. Hemmer, L. Kappos, R. Liblau, C. Lubetzki, E. Marcus, D. H. Miller, T. Olsson, S. Pilling, K. Selmaj, A. Siva, P. S. Sorensen, M. P. Sormani, C. Thalheim, H. Wiendl & F. Zipp. (2018)
ECTRIMS
/
EAN
guideline on the pharmacological treatment of people with multiple sclerosis
. European Journal of Neurology 25:2, pages 215-237.
Crossref
Crossref
Johanna Jonsdottir, Rita Bertoni, Michael Lawo, Angelo Montesano, Thomas Bowman & Silvia Gabrielli. (2018) Serious games for arm rehabilitation of persons with multiple sclerosis. A randomized controlled pilot study. Multiple Sclerosis and Related Disorders 19, pages 25-29.
Crossref
Crossref
Yeliz Karaca, Carlo Cattani & Rana Karabudak. 2018. Computational Science and Its Applications – ICCSA 2018. Computational Science and Its Applications – ICCSA 2018
121
136
.
Marcello Moccia, Raffaele Palladino, Roberta Lanzillo, Antonio Carotenuto, Cinzia Valeria Russo, Maria Triassi & Vincenzo Brescia Morra. (2017) Healthcare Costs for Treating Relapsing Multiple Sclerosis and the Risk of Progression: A Retrospective Italian Cohort Study from 2001 to 2015. PLOS ONE 12:1, pages e0169489.
Crossref
Crossref